https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Based on the subgroup analysis, adjuvant chemotherapy should also be considered when visceral pleural involvement is present even if the tumor size is less than 3cm. Adjuvant chemotherapy may be useful for patients with stage IB NSCLC with high-risk factors and more relevant for patients with visceral pleural involvement or vascular invasion. Adjuvant chemotherapy may be useful for patients with stage IB NSCLC with high-risk factors and more relevant for patients with visceral pleural involvement or vascular invasion. Coron
Curtir
Comentario
Compartilhar
